Other Species / Isoforms
  CDK5R1 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S6
__MGTVLSLsPSYRK
0 1
CDK5R1 (human) __MGTVLSLsPSYRK S6
CDK5R1 (mouse) __MGTVLsLsPSYRK S6-p
CDK5R1 (rat) __MGTVLSLsPSYRK S6
S8-p
MGTVLSLsPSYRKAT
Upstream
7 1
Putative in vivo kinases:
  • CDK5 (human)
CDK5R1 (human) MGTVLSLsPSYRKAT S8-p
CDK5R1 (mouse) MGTVLsLsPSYRKAT S8-p
CDK5R1 (rat) MGTVLSLsPSYRKAT S8-p
S33
HYTAVQNSKNAKDKN
1 0
CDK5R1 (human) HYTAVQNSKNAKDKN S33
CDK5R1 (mouse) HYTAVQNsKNAKDKN S33-p
CDK5R1 (rat) HYTAVQNSKNAKDKN S33
S91-p
ENLKKSLsCANLSTF
Upstream
4 0
Kinase, in vitro:
  • CAMK2A (human)
CDK5R1 (human) ENLKKSLsCANLSTF S91-p
CDK5R1 (mouse) ENLKKSLsCANLSTF S91-p
CDK5R1 (rat) ENLKKSLsCANLSTF S91-p
T138-p
PAITSAGtPKRVIVQ
Upstream
Downstream
8 2
Effects on Modified Protein
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, inhibited
  • signaling pathway regulation
Putative in vivo kinases:
  • CDK5 (human)
Regulatory protein:
  • NGFR (rat)
  • PTPN13 (human)
Treatment
  • GTP
  • intracerebral hemorrhage
  • okadaic_acid
  • thrombin
CDK5R1 (human) PAVTSAGtPKRVIVQ T138-p
CDK5R1 (mouse) PAITSAGtPKRVIVQ T138-p
CDK5R1 (rat) PAITSAGtPKRVIVQ T138-p
Y234
LTCLYLSYSYMGNEI
1 0
CDK5R1 (human) LTCLYLSySYMGNEI Y234-p
CDK5R1 (mouse) LTCLYLSYSYMGNEI Y234
CDK5R1 (rat) LTCLYLSYSYMGNEI Y234